CheckMyRecalls

Amneal Pharmaceuticals, LLC recalls Ropivacaine Hydrochloride Injection

Published
14 May 2025
Units affected
62 (12x100mL) bags
Agency
FDA
Country
United States

The hazard

Presence of Particulate Matter

Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box)

Brand / company
Amneal Pharmaceuticals, LLC
Codes / lots
Lot #'s: AL240003, AL240004, Exp.: 01/31/2026
Distribution
Nationwide in the US
Recall status
Terminated

Source: U.S. Food and Drug Administration, published 14 May 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.